Biopharma Insights - page 22

Professor Sidney Altman

Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is outstanding researcher, who first discovered the catalytical properties of RNA. …

Continue ›››

Virtual Reality in Drug Discovery: More Useful Than You Probably Think

Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design is an interesting and emerging technological opportunity.

Continue ›››

Choosing The Right CRO For Pharma R&D Outsourcing

This post was originally published on Quora, answering the question: "How do drug manufacturers select the right contract research organization(CRO)?" Selecting the right contract research organization (CRO ) obviously depends on …

Continue ›››

Are We Keeping Up With Antimicrobial Resistance?

Antimicrobial resistance (AMR) poses a major threat to human health. There were an estimated 4.95M deaths associated with bacterial AMR in 2019, including 1.27M deaths attributable to bacterial AMR. Lower …

Continue ›››

Bringing “Everything on Demand” to Longevity Industry

Deep Knowledge Group, a UK-based consortium of commercial and non-for-profit companies in the domain of longevity industry and deep tech investments announced the launch of its Swiss-based subsidiary Quant Biomarkers. …

Continue ›››

Ups and Downs of Adenovirus and Adeno-Associated Virus Vectors in Gene Therapy

Gene therapy is still an investigational technique. Viruses are commonly used as vectors to deliver a needed gene to a host (defective) cell. An ideal viral vector is supposed to …

Continue ›››

Antisense Oligonucleotides Make Sense

Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are complementary to a chosen sequence. They can alter RNA and …

Continue ›››

What are the ADC drugs?

The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging for so many years? What kind of "magic" power it …

Continue ›››

Companies Driving Innovation To Fight Alzheimer’s Disease

The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even a century ago, led to a substantial growth of the …

Continue ›››

Contract Research Organizations Tap Into AI To Increase Value Proposition

A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to get a drug or medical device to market. Nowadays, nearly …

Continue ›››

Clinical Research, Artificial Intelligence, and COVID-19

How life sciences companies are reimagining trials during the biggest health crisis in a century Whatever the world was like on March 15, it’s not like that now — and …

Continue ›››

How To Be Ready For Future Pandemics?

What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they both have been commercially unattractive targets for the pharma business …

Continue ›››